ai3Bio
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $48M
Investors
- 4
About ai3Bio
based in Massachusetts, US, and co-founded in 2025, ai3Bio is a biotechnology company that research and develops immunology-based therapies for autoimmune diseases through its platforms use lipid nanoparticle (LNP)/mRNA and antibody technologies to identify and eliminate disease-causing T cells directly in vivo, aiming to restore immune balance at the source of disease.
Who invested in ai3Bio
4 investors across 1 round
See all investors in ai3Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 29, 2026
Amount
$48M
Investors
Questions about ai3Bio
Who invested in ai3Bio?
ai3Bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ai3Bio raised?
ai3Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ai3Bio last raise money?
ai3Bio's most recent round on record is a Series A, in Sep 2026.
What does ai3Bio do?
based in Massachusetts, US, and co-founded in 2025, ai3Bio is a biotechnology company that research and develops immunology-based therapies for autoimmune diseases through its platforms use lipid nanoparticle (LNP)/mRNA and antibody technologies to identify and eliminate disease-causing T cells directly in vivo, aiming to restore immune balance at the source of disease.
Where is ai3Bio headquartered?
ai3Bio is headquartered in US.
Which VCs invest in companies like ai3Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ai3Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ai3Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.